BMC Medical Co. Ltd. A (301367) — Cash Flow Reinvestment Rate

Latest as of December 2025: 6.50x

BMC Medical Co. Ltd. A (301367) has a Cash Flow Reinvestment Rate of 6.50x as of December 2025, reinvesting CN¥846.58 Million (capex CN¥32.22 Million plus investments CN¥814.36 Million) from operating cash flow of CN¥130.16 Million. See BMC Medical Co. Ltd. A (301367) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

6.50x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥846.58 Million
Capex + Investments

Operating Cash Flow

CN¥130.16 Million
CNY

Capital Expenditures

CN¥32.22 Million
CNY

BMC Medical Co. Ltd. A Cash Flow Reinvestment Rate (2020–2025)

Historical reinvestment intensity for BMC Medical Co. Ltd. A across 6 annual periods. For the full cash flow conversion analysis, see 301367 operating cash flow.

Annual Cash Flow Reinvestment Rate for BMC Medical Co. Ltd. A (2020–2025)

Year-by-year capital reinvestment analysis for BMC Medical Co. Ltd. A. See 301367 financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2025 6.50x CN¥846.58 Million CN¥130.16 Million CN¥32.22 Million ▲ +76.3%
2024 3.69x CN¥568.33 Million CN¥154.08 Million CN¥15.93 Million ▲ +71.0%
2023 2.16x CN¥326.03 Million CN¥151.11 Million CN¥24.12 Million ▼ -57.4%
2022 5.06x CN¥1.90 Billion CN¥375.21 Million CN¥23.75 Million ▲ +185.9%
2021 1.77x CN¥184.90 Million CN¥104.40 Million CN¥10.03 Million ▲ +475.7%
2020 0.31x CN¥82.26 Million CN¥267.41 Million CN¥15.43 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow